{"id":396275,"date":"2020-12-09T08:03:34","date_gmt":"2020-12-09T13:03:34","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=396275"},"modified":"2020-12-09T08:03:34","modified_gmt":"2020-12-09T13:03:34","slug":"lineage-cell-therapeutics-to-present-at-the-13th-annual-ld-micro-main-event-conference-on-december-14-2020","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/lineage-cell-therapeutics-to-present-at-the-13th-annual-ld-micro-main-event-conference-on-december-14-2020\/","title":{"rendered":"Lineage Cell Therapeutics to Present at the 13th Annual LD Micro Main Event Conference on December 14, 2020"},"content":{"rendered":"

<\/p>\n

Lineage Cell Therapeutics to Present at the 13th<\/sup> Annual LD Micro Main Event Conference on December 14, 2020<\/b><\/p>\n

CARLSBAD, Calif.–(BUSINESS WIRE<\/a>)–Lineage Cell Therapeutics, Inc.<\/a> (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing three novel cell therapies for serious medical conditions, today announced that Brian M. Culley, Chief Executive Officer, will be presenting at the 13th<\/sup> Annual LD Micro Main Event<\/a> virtual conference on December 14, 2020 at 12:00 pm Eastern Time \/ 9:00am Pacific Time. Interested investors can register and access the live presentation on the 13th<\/sup> Annual LD Micro Main Event<\/a> conference page as well as on the Events and Presentations<\/a> section of Lineage\u2019s website.\n<\/p>\n

\nThe archived presentation will be available on the Events and Presentations<\/a> section of Lineage\u2019s website for 30 days. Additional videos are available on the Media page of the Lineage website, located at www.lineagecell.com\/media\/<\/a>.\n<\/p>\n

About Lineage Cell Therapeutics, Inc. <\/b><\/p>\n

\nLineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage\u2019s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Lineage\u2019s clinical programs are in markets with billion dollar opportunities and include three allogeneic (\u201coff-the-shelf\u201d) product candidates: (i) OpRegen\u00ae<\/sup>, a retinal pigment epithelium transplant therapy in Phase 1\/2a development for the treatment of dry age-related macular degeneration, a leading cause of blindness in the developed world; (ii) OPC1, an oligodendrocyte progenitor cell therapy in Phase 1\/2a development for the treatment of acute spinal cord injuries; and (iii) VAC, an allogeneic dendritic cell therapy platform for immuno-oncology and infectious disease, currently in clinical development for the treatment of non-small cell lung cancer. For more information, please visit www.lineagecell.com<\/a> or follow the Company on Twitter @LineageCell<\/a>.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20201209005296\/en\/<\/a><\/span><\/p>\n

Lineage Cell Therapeutics, Inc. IR
\n<\/b>
Ioana C. Hone
\n
(ir@lineagecell.com<\/a>)
\n
(442) 287-8963\n<\/p>\n

Solebury Trout IR
\n<\/b>
Gitanjali Jain Ogawa
\n
(Gogawa@troutgroup.com<\/a>)
\n
(646) 378-2949\n<\/p>\n

Russo Partners \u2013 Media Relations
\n<\/b>
Nic Johnson or David Schull
\n
Nic.johnson@russopartnersllc.com
\n<\/a>
David.schull@russopartnersllc.com
\n<\/a>
(212) 845-4242\n<\/p>\n

KEYWORDS:<\/b> California United States North America<\/p>\n

INDUSTRY KEYWORDS:<\/b> Oncology Health Genetics Clinical Trials Pharmaceutical Biotechnology<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Lineage Cell Therapeutics to Present at the 13th Annual LD Micro Main Event Conference on December 14, 2020 CARLSBAD, Calif.–(BUSINESS WIRE)–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing three novel cell therapies for serious medical conditions, today announced that Brian M. Culley, Chief Executive Officer, will be presenting at the 13th Annual LD Micro Main Event virtual conference on December 14, 2020 at 12:00 pm Eastern Time \/ 9:00am Pacific Time. Interested investors can register and access the live presentation on the 13th Annual LD Micro Main Event conference page as well as on the Events and Presentations section of Lineage\u2019s website. The archived presentation will be available on the Events and Presentations section … <\/p>\n

Continue reading “Lineage Cell Therapeutics to Present at the 13th Annual LD Micro Main Event Conference on December 14, 2020”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-396275","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nLineage Cell Therapeutics to Present at the 13th Annual LD Micro Main Event Conference on December 14, 2020 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lineage-cell-therapeutics-to-present-at-the-13th-annual-ld-micro-main-event-conference-on-december-14-2020\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lineage Cell Therapeutics to Present at the 13th Annual LD Micro Main Event Conference on December 14, 2020 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Lineage Cell Therapeutics to Present at the 13th Annual LD Micro Main Event Conference on December 14, 2020 CARLSBAD, Calif.–(BUSINESS WIRE)–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing three novel cell therapies for serious medical conditions, today announced that Brian M. Culley, Chief Executive Officer, will be presenting at the 13th Annual LD Micro Main Event virtual conference on December 14, 2020 at 12:00 pm Eastern Time \/ 9:00am Pacific Time. Interested investors can register and access the live presentation on the 13th Annual LD Micro Main Event conference page as well as on the Events and Presentations section of Lineage\u2019s website. The archived presentation will be available on the Events and Presentations section … Continue reading "Lineage Cell Therapeutics to Present at the 13th Annual LD Micro Main Event Conference on December 14, 2020"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/lineage-cell-therapeutics-to-present-at-the-13th-annual-ld-micro-main-event-conference-on-december-14-2020\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-09T13:03:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201209005296r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lineage-cell-therapeutics-to-present-at-the-13th-annual-ld-micro-main-event-conference-on-december-14-2020\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lineage-cell-therapeutics-to-present-at-the-13th-annual-ld-micro-main-event-conference-on-december-14-2020\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Lineage Cell Therapeutics to Present at the 13th Annual LD Micro Main Event Conference on December 14, 2020\",\"datePublished\":\"2020-12-09T13:03:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lineage-cell-therapeutics-to-present-at-the-13th-annual-ld-micro-main-event-conference-on-december-14-2020\\\/\"},\"wordCount\":434,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lineage-cell-therapeutics-to-present-at-the-13th-annual-ld-micro-main-event-conference-on-december-14-2020\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201209005296r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lineage-cell-therapeutics-to-present-at-the-13th-annual-ld-micro-main-event-conference-on-december-14-2020\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lineage-cell-therapeutics-to-present-at-the-13th-annual-ld-micro-main-event-conference-on-december-14-2020\\\/\",\"name\":\"Lineage Cell Therapeutics to Present at the 13th Annual LD Micro Main Event Conference on December 14, 2020 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lineage-cell-therapeutics-to-present-at-the-13th-annual-ld-micro-main-event-conference-on-december-14-2020\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lineage-cell-therapeutics-to-present-at-the-13th-annual-ld-micro-main-event-conference-on-december-14-2020\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201209005296r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2020-12-09T13:03:34+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lineage-cell-therapeutics-to-present-at-the-13th-annual-ld-micro-main-event-conference-on-december-14-2020\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lineage-cell-therapeutics-to-present-at-the-13th-annual-ld-micro-main-event-conference-on-december-14-2020\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lineage-cell-therapeutics-to-present-at-the-13th-annual-ld-micro-main-event-conference-on-december-14-2020\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201209005296r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201209005296r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lineage-cell-therapeutics-to-present-at-the-13th-annual-ld-micro-main-event-conference-on-december-14-2020\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lineage Cell Therapeutics to Present at the 13th Annual LD Micro Main Event Conference on December 14, 2020\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lineage Cell Therapeutics to Present at the 13th Annual LD Micro Main Event Conference on December 14, 2020 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/lineage-cell-therapeutics-to-present-at-the-13th-annual-ld-micro-main-event-conference-on-december-14-2020\/","og_locale":"en_US","og_type":"article","og_title":"Lineage Cell Therapeutics to Present at the 13th Annual LD Micro Main Event Conference on December 14, 2020 - Market Newsdesk","og_description":"Lineage Cell Therapeutics to Present at the 13th Annual LD Micro Main Event Conference on December 14, 2020 CARLSBAD, Calif.–(BUSINESS WIRE)–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing three novel cell therapies for serious medical conditions, today announced that Brian M. Culley, Chief Executive Officer, will be presenting at the 13th Annual LD Micro Main Event virtual conference on December 14, 2020 at 12:00 pm Eastern Time \/ 9:00am Pacific Time. Interested investors can register and access the live presentation on the 13th Annual LD Micro Main Event conference page as well as on the Events and Presentations section of Lineage\u2019s website. The archived presentation will be available on the Events and Presentations section … Continue reading \"Lineage Cell Therapeutics to Present at the 13th Annual LD Micro Main Event Conference on December 14, 2020\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/lineage-cell-therapeutics-to-present-at-the-13th-annual-ld-micro-main-event-conference-on-december-14-2020\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-09T13:03:34+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201209005296r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lineage-cell-therapeutics-to-present-at-the-13th-annual-ld-micro-main-event-conference-on-december-14-2020\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lineage-cell-therapeutics-to-present-at-the-13th-annual-ld-micro-main-event-conference-on-december-14-2020\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Lineage Cell Therapeutics to Present at the 13th Annual LD Micro Main Event Conference on December 14, 2020","datePublished":"2020-12-09T13:03:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lineage-cell-therapeutics-to-present-at-the-13th-annual-ld-micro-main-event-conference-on-december-14-2020\/"},"wordCount":434,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lineage-cell-therapeutics-to-present-at-the-13th-annual-ld-micro-main-event-conference-on-december-14-2020\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201209005296r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lineage-cell-therapeutics-to-present-at-the-13th-annual-ld-micro-main-event-conference-on-december-14-2020\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/lineage-cell-therapeutics-to-present-at-the-13th-annual-ld-micro-main-event-conference-on-december-14-2020\/","name":"Lineage Cell Therapeutics to Present at the 13th Annual LD Micro Main Event Conference on December 14, 2020 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lineage-cell-therapeutics-to-present-at-the-13th-annual-ld-micro-main-event-conference-on-december-14-2020\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lineage-cell-therapeutics-to-present-at-the-13th-annual-ld-micro-main-event-conference-on-december-14-2020\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201209005296r1&sid=flmnd&distro=nx&lang=en","datePublished":"2020-12-09T13:03:34+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lineage-cell-therapeutics-to-present-at-the-13th-annual-ld-micro-main-event-conference-on-december-14-2020\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/lineage-cell-therapeutics-to-present-at-the-13th-annual-ld-micro-main-event-conference-on-december-14-2020\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lineage-cell-therapeutics-to-present-at-the-13th-annual-ld-micro-main-event-conference-on-december-14-2020\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201209005296r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201209005296r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lineage-cell-therapeutics-to-present-at-the-13th-annual-ld-micro-main-event-conference-on-december-14-2020\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Lineage Cell Therapeutics to Present at the 13th Annual LD Micro Main Event Conference on December 14, 2020"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/396275","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=396275"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/396275\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=396275"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=396275"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=396275"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}